AADI BIOSCIENCE
Live / Registered — Registered (as of 13 Oct 2026)
What this means for you
Registered since 13 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 99464339
- Registration number
- 8505918
- Mark type
- Word mark
- Filed
- 27 Oct 2025
- Published for opposition
- 07 Apr 2026
- Registered
- 13 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 13 Oct 2032 (grace period to 13 Apr 2033)
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Vaccine preparations; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in the treatment of diseases and disorders in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; Pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in pediatric, geriatric, emergency, family, and human preventative medicine for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, epilepsy and mitochondrial disease; Pharmaceutical preparations for the treatment of vascular malformations; Pharmaceutical preparations for the prevention and treatment of vascular system related diseases and disorders; Pharmaceutical preparations for use in plastic surgery; Pharmaceutical preparations for the treatment of tissue overgrowth related diseases and disorders; Pharmaceutical preparations for the treatment of vascular anomalies; all of the foregoing excluding pharmaceutical preparations for the treatment of sexual dysfunction and sexual disorders
Owner
- Aadi Bioscience, Inc., Morristown, NJ, US
- Aadi Bioscience, Inc., Morristown, NJ, US
- Aadi Bioscience, Inc., Morristown, NJ, US
Prosecution history
- 13 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 23 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Sept 2026 — USE AMENDMENT FILED
- 02 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 02 Jul 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 25 Jun 2026 — ASSIGNED TO PETITION STAFF
- 02 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 May 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 07 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Apr 2026 — PUBLISHED FOR OPPOSITION
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER